Development And Application of Risk Management System For Consumer Products In Compliance With Global Harmonization

By Song Jae Bin   Ahn Il Young   Cho Keun Tae   Kim Yeon Joo   Kim Hyung Sik   Lee Byung-Mu  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 16, Iss. 1, 2013-01 ,pp. : 1-16

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clinical Risk Management of Interactions Between Natural Products and Drugs

By  

Current Drug Metabolism, Vol. 9, Iss. 10, 2008-12 ,pp. : 1055-1062

Bentham Science Publishers

Access to resources Recommend Favorite

Do Biological Medicinal Products Pose a Risk to the Environment?: A Current View on Ecopharmacovigilance

By Kühler Thomas C.   Andersson Mikael   Carlin Gunnar   Johnsson Ann   Åkerblom Lennart  

Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. : 995-1000

Adis International

Access to resources Recommend Favorite

The Japan PDMA will require pharmaceutical companies to include risk management plans in all applications, for new drug or biosimilar products

By  

Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Biological Interpretation of Relative Risk

By Lanes S.F.  

Drug Safety, Vol. 21, Iss. 2, 1999-08 ,pp. : 75-79

Adis International

Access to resources Recommend Favorite